Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 21, 2026

Netflix (NFLX) Q4 2025 Earnings Call Transcript

View original at nasdaq.com
Netflix (NFLX) Q4 2025 Earnings Call Transcript Image source: The Motley Fool. Date Tuesday, Jan. 20, 2026 at 4:45 p.m…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • YouTube surpassed BBC monthly average audience in the UK according to Barb

    80% confidence
  • Japanese consumers watch 50-67% less TV than US consumers

    80% confidence
  • Q2 2024 revenue growth was 17% reported

    80% confidence
  • The Warner Bros. acquisition represents a tremendous, very achievable opportunity

    80% confidence
  • Post-acquisition, 85% of Netflix revenue will come from current core businesses

    80% confidence
  • Netflix will spend $17 billion on content cash in 2026, growing slower than revenue

    80% confidence
  • Netflix will add 2+ live operation centers in 2026 in UK and Asia

    80% confidence
  • The Warner Bros. deal is pro-consumer, pro-innovation, pro-worker, pro-creator, and pro-growth

    80% confidence
  • Approximately one-third of Netflix members have access to TV-based games through client upgrades

    80% confidence
  • Post-launch party pack games (Boggle, Pictionary, LEGO) achieved approximately 10% reach into eligible members

    80% confidence
  • Ad-supported ARM is currently below ad-free ARM, representing a monetization gap

    80% confidence
  • Netflix 2025 operating margin reached 26%, raised from 25% guidance

    80% confidence
  • 2026 operating margin will be 2.5 points higher excluding M&A expenses

    80% confidence
  • There are 500+ million smart TV households globally that are non-Netflix members

    80% confidence
  • Netflix has less than 10% of TV time in all major markets

    80% confidence
  • Gaming market size is approximately $140 billion in consumer spend excluding China

    80% confidence
  • Live events represent a relatively small portion of total view hours

    80% confidence
  • Netflix forecasts 2026 revenue of $51 billion, representing 14% year-over-year growth

    80% confidence
  • Netflix ad revenue was 2.5x higher in 2025 compared to prior year

    80% confidence
  • Customer satisfaction reached all-time high

    80% confidence
  • Warner Bros. global box office exceeds $4 billion

    80% confidence
  • Netflix executed 200+ live events

    80% confidence
  • Netflix has approximately 7% of addressable consumer and ad spend globally

    80% confidence
  • Q2 2024 had strong acquisition and healthy retention across all regions

    80% confidence
  • Netflix operating profit grew approximately 30% in 2025

    80% confidence
  • Netflix expects approximately $6 billion in free cash flow for 2026

    80% confidence
  • Total Netflix view hours grew 2% year-over-year in 2025, adding 1.5 billion hours, accelerating from 1% in prior year

    80% confidence
  • Q2 2024 operating margin expanded 5 percentage points year-over-year

    80% confidence
  • Netflix targets 2026 operating margin of 31.5%, up 2 percentage points including 0.5 point M&A expense headwind

    80% confidence
  • Netflix retention is among the best in the industry

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Netflix (NFLX) Q4 2025 Earnings Call Transcript — Source | Via News | ViaNews Market